[Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. (Record no. 28667295)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01277 a2200349 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517230937.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201907s 0 0 chi d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1007-8738 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Dai, Jimin |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190708 |
| 245 00 - TITLE STATEMENT | |
| Title | [Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology |
| Date of publication, distribution, etc. | May 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 427-433 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Apoptosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Hepatocellular |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Neoplasm |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Liver Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nuclear Proteins |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proto-Oncogene Proteins c-akt |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sorafenib |
| General subdivision | pharmacology |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Niu, Kunwei |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, Bo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Yijie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Xia, Congcong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tao, Kaishan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dai, Jingyao |
| 773 0# - HOST ITEM ENTRY | |
| Title | Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology |
| Related parts | vol. 34 |
| -- | no. 5 |
| -- | p. 427-433 |
No items available.